Vitrolife AB (publ)
VTRLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $3 | $2 |
| % Growth | 2.8% | 8.6% | 92.4% | – |
| Cost of Goods Sold | $1 | $2 | $1 | $1 |
| Gross Profit | $2 | $2 | $2 | $1 |
| % Margin | 59.3% | 56.3% | 55% | 62.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $4 | $0 | $0 |
| Operating Expenses | $1 | $6 | $1 | $1 |
| Operating Income | $1 | -$4 | $1 | $0 |
| % Margin | 21.7% | -102.2% | 20.2% | 25.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $1 | -$4 | $1 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | -$4 | $0 | $0 |
| % Margin | 14.2% | -109.7% | 12.2% | 20.3% |
| EPS | 3.79 | -28.44 | 2.91 | 2.97 |
| % Growth | 113.3% | -1,077.3% | -2% | – |
| EPS Diluted | 3.78 | -28.44 | 2.91 | 2.97 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | -$3 | $1 | $1 |
| % Margin | 32.1% | -90.9% | 30.2% | 34.4% |